IL13

  • 1 trial
  • Funder: National Heart, Lung, and Blood Institute
  • 1 of 1 trial sponsored by developers of drugs on it
  • Humans1

Funding

1 grant since 2023

National Heart, Lung, and Blood InstituteUS$447.1k

Latest